FRANKLIN RESOURCES INC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$2,852,000
+22.4%
122,711
-16.1%
0.00%0.0%
Q1 2018$2,330,000
-29.9%
146,299
-36.9%
0.00%
-50.0%
Q3 2017$3,322,000
-28.2%
231,842
-13.3%
0.00%0.0%
Q2 2017$4,629,000
+21.8%
267,546
-22.4%
0.00%0.0%
Q1 2017$3,802,000
+12.0%
344,689
+47.4%
0.00%0.0%
Q4 2016$3,396,000
-68.0%
233,866
-46.0%
0.00%
-66.7%
Q3 2016$10,625,000
+30.9%
432,801
+7.4%
0.01%
+50.0%
Q2 2016$8,114,000
-18.3%
402,925
+6.6%
0.00%
-20.0%
Q1 2016$9,932,000
-66.4%
377,843
+29.9%
0.01%
-66.7%
Q4 2015$29,566,000
-88.5%
290,884
-79.8%
0.02%
-88.2%
Q3 2015$257,085,000
-27.3%
1,441,130
-9.4%
0.13%
-20.6%
Q2 2015$353,449,000
+23.1%
1,591,084
+10.1%
0.16%
+23.1%
Q1 2015$287,116,000
+65.9%
1,445,747
+19.6%
0.13%
+66.7%
Q4 2014$173,067,000
+28.6%
1,209,275
+17.9%
0.08%
+27.9%
Q3 2014$134,603,000
+18.4%
1,026,019
+13.8%
0.06%
+22.0%
Q2 2014$113,698,000
+18.1%
901,378
+23.4%
0.05%
+11.1%
Q1 2014$96,281,000
+244.2%
730,671
+206.5%
0.04%
+221.4%
Q4 2013$27,974,000
+29.9%
238,371
+15.4%
0.01%
+27.3%
Q3 2013$21,542,000
+26.7%
206,560
+4.6%
0.01%
+10.0%
Q2 2013$17,009,000197,4000.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2015
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders